Current Clinical Research Trials for Multiple Sclerosis

Researchers at The GW Medical Faculty Associate’s Department of Neurology are conducting clinical research trials to learn more about treating multiple sclerosis (MS). 

Clinical research trials search for new ways to prevent, understand and/or treat disease. The goal of these trials is to see if a new treatment, procedure or device works and is safe to use.  Participating in a research trial, as either a healthy volunteer or a patient volunteer, is an opportunity to help researchers find better treatments for others in the future.

The following are clinical research trials specific to Multiple Sclerosis:

 

PASSAGE

Study Title: PASSAGE: Long-term, prospective, multinational, paralell-cohort study monitoring safety in patients with MS newly started on fingolimod once daily or treated with another approved disease-modifying therapy

Principal Investigator: Ted Rothstein, MD

Sponsor: Novartis

Study Description: The purpose of this observational study is to assess the overall long-term clinical effectiveness of and to monitor the safety and tolerability of fingolimod (Gilenya™) in patients with relapsing forms of MS in routine clinical practice.

Contact Information: For more information, interested participants and clinicians may contact the Neurology Clinical Research unit at neurostudies@mfa.gwu.edu